Sarah Rutherford

11PUBLICATIONS
69CO-AUTHORS
Haematological tumoursLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDiagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 09, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.

Sharon M Castellino, Hongli Li, Alex F Herrera

|Dec 03, 2025
Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop.

Reid Merryman, Sarah C Rutherford, Stephen Ansell

|Jun 16, 2025
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.

Sarah C Rutherford, Hongli Li, Alex F Herrera

|Feb 28, 2025
The future of follicular lymphoma management: strategies on the horizon.

Erin Mulvey, Sarah C Rutherford, John P Leonard

|Oct 06, 2023
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.

Rossella Marullo, Sarah C Rutherford, Maria V Revuelta

|Jul 05, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.

Sarah C Rutherford, Jun Yin, Levi Pederson

Pageof 2

Frequent Collaborators

3 joint publications

Peter Martin

3 joint publications

Joseph M Unger

2 joint publications

Joo Y Song

2 joint publications

Hongli Li